#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Advanced systemic mastocytosis Hodgkin's disease refractory Hereditary motor and sensory neuropathy Vernal keratoconjunctivitis Juvenile chronic myelomonocytic leukaemia Follicular lymphoma stage II Precursor T-lymphoblastic lymphoma/leukaemia recurrent Netherton's syndrome Infantile apnoea Acromegaly Epilepsy Scleroderma associated digital ulcer Haemophilia B without inhibitors Squamous cell carcinoma of the cervix Friedreich's ataxia More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Diagnostics Myxofibrosarcoma – Trials in Disease Angelman’s syndrome – Trials in Disease Acquired haemophilia Loeys-Dietz syndrome – Diagnostics Pleomorphic leiomyosarcoma – Trials in Disease Osteosarcoma metastatic – Basic Information Mantle cell lymphoma stage IV – Diagnostics Hereditary hypophosphataemic rickets Pleomorphic leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zinc Sulphate Heptahydrate Pyridoxine Hydrochloride Codeine Phosphate Hemihydrate Lovastatin Clonidine Hydrochloride Benralizumab Rosuvastatin Calcium Vutrisiran GSKVX000000030810 Inclisiran Povidone, Iodinated 177LU-FAP-2286 Gad20-209-Fsp-A2 Methyl Aminolevulinate Navtemadlin Cevostamab ATIGOTATUG Elotuzumab AMG 732 Pyridoxine Hydrochloride Bp More therapies…

    Learn about Your Condition

    Gastrooesophageal cancer Myasthenia gravis Small fibre neuropathy Clostridium difficile colitis Supraventricular tachycardia Diabetic autonomic neuropathy Multiple sclerosis relapse Viral infection Patent ductus arteriosus Hypogonadism male Mantle cell lymphoma Thymic carcinoma Hypoglycaemia Hypomagnesaemia Diffuse large B-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study on the Effectiveness and Safety of Pembrolizumab, Canakinumab, and Chemotherapy for Untreated Advanced Non-Small Cell Lung Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Canakinumab
    • Pemetrexed Disodium
    Germany Spain

  • Study of Chemotherapy and Nivolumab for Patients with Locally Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nivolumab
    Spain

  • Study of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    • Malignant melanoma
    • Non-small cell lung cancer
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Aldesleukin
    • Lifileucel
    Germany Greece Spain

  • Study on the Effectiveness of Retifanlimab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Diacid Monohydrate
    • Retifanlimab
    • Pemetrexed Disodium
    Bulgaria Czechia

  • Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Belgium France Germany Italy Poland Spain

  • Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lazertinib
    • Osimertinib
    • Amivantamab
    Belgium France Germany Hungary Italy The Netherlands +3
Previous Page
1 … 39 40 41 42 43 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!